Baker Bros. Advisors LP Ionis Pharmaceuticals Inc Call Options Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IONS
# of Institutions
416Shares Held
140MCall Options Held
861KPut Options Held
714K-
Vanguard Group Inc Valley Forge, PA16.5MShares$511 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$440 Million0.31% of portfolio
-
Capital World Investors Los Angeles, CA11.5MShares$356 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$320 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.67MShares$269 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $4.41B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...